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Surveillance programmes of antimicrobial resistance all
over the world show progressive increase in resistance
among isolates of Streptococcus pneumoniae and other
common respiratory tract pathogens. The tracking
resistance in the United States today (TRUST) study,
started in 1996, has demonstrated an increase in high-
level penicillin resistance (MIC >2 lg/ml) to 16.9% in
2001 among respiratory strains of S. pneumoniae; the
resistance to azithromycin was found to be 23% during
the 1998–1999 respiratory tract infection season, com-
pared to 28% during the 2000–2001 season [3]. The US-
focused component of the prospective resistant organ-
ism tracking and epidemiology for the ketolide teli-
thromycin (PROTEKT US) study showed marked
variability in the prevalence of penicillin resistance
among strains of S. pneumoniae in diﬀerent regions of
the United States. The penicillin resistance was most
pronounced in the south-eastern and south-central states
(36.4% and 32.5%, respectively) and lowest in the
north-western region (17.3%). Macrolide resistance was
also most prevalent in the south-eastern and south-
central states (40.2% and 38.6%, respectively) and
lowest in the north-western region (23.2%) [3]. Similar
data are available for Europe. In Portugal, the resistance
to penicillin (including reduced susceptibility) and to
erythromycin of S. pneumoniae isolates recovered from
children <6 years with invasive disease were 43.9% and
20.7%, respectively [5]. In Spain, a number of geo-
graphical regions had rates of erythromycin resistant S.
pneumoniae above 40% (even higher in children) [4].
The report of Jaecklin et al. [2] that appears in this
issue shows increasing resistance of respiratory patho-
gens in children in Geneva, Switzerland, from 1989 to
2004. The susceptibility of S. pneumoniae to penicillin
and to erythromycin has decreased from 98% to 58%
and from 97% to 63%, respectively. The resistance is
similar to neighbouring France rather than to the rest of
Switzerland with much less resistance problems. Geneva
is a city with international organisations and has many
inhabitants coming from countries with higher bacterial
resistance rates, mainly from France. Furthermore, the
consumption of antibiotics in this region seems to be
higher than in other parts of Switzerland. The report of
Arri et al. [1], also appearing in this issue, shows still a
low rate of penicillin resistant S. pneumoniae (overall
penicillin resistance of 3.5%) in children in Freiburg,
Germany; erythromycin resistance increased signiﬁ-
cantly from 5% in 1993 to 12.2% in 2002. Freiburg is
also located near France, but is a German speaking city
and the contact with French speaking people from
neighbouring France might be less intensive than in
Geneva. The trend in antibiotic resistance in regions
neighbouring a high level resistance region might also
depend from the interaction of two populations.
These two reports of Arri et al. [1] and Jaecklin et al.
[2] are of great value since the regional development of
resistance of S. pneumoniae, Haemophilus inﬂuenzae and
Moraxella catarrhalis to several antibiotics is described
for over 10 and 15 years, respectively. They show once
more that the frequency of resistance is very diﬀerent
from one region to another even if they are both bor-
dering a high level resistance country and relatively close
to each other (less than 300 km). Switzerland has very
heterogeneous small regions with diﬀerent populations;
a resistance statistic of the whole country represents not
the situation in all individual regions. Regional resis-
tance statistics are very important for local guidelines of
the empiric therapy of respiratory infections. The
international guidelines must include high level resis-
tance countries and promote the use of more potent
antibiotics. In adults, modern quinolones are now often
used for the empiric therapy because all relevant respi-
ratory pathogens are susceptible to modern quinolones
and resistance problems of beta-lactams are solved. The
consumption of quinolones increases and induces a
selection pressure on the chinolone resistant bacteria,
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e.g. methicillin resistant Staphylococcus aureus in the
large area of Zurich are rarely multiresistant, but mostly
resistant to quinolones. The increase of resistance
among respiratory tract pathogens can only be slowed if
consumption of antibiotics is restricted to true bacterial
infections and is according to local resistance patterns.
Rapid identiﬁcation of the responsible agent of a respi-
ratory infection as well as therapy guidelines can support
an adequate narrow empiric therapy of respiratory tract
pathogens or avoid unnecessary therapy. Resistance
problems are global, but antibiotic restriction must be
local.
References
1. Arri SJ, Fluegge K, Mueller U, Berner R (2005) Antibiotic
resistance patterns among respiratory pathogens at a German
university children’s hospital over a period of 10 years. Eur
J Pediatr (this issue)
2. Jaecklin T, Rohner P, Jacomo V, Schmidheiny K, Gervaix A
(2005) Trends in antibiotic resistance of respiratory pathogens in
children in Geneva, Switzerland. Eur J Pediatr (this isue)
3. Karchmer AW (2004) Increased antibiotic resistance in respira-
tory tract pathogens: PROTEKT US–an update. Clin Infect Dis
39: S142–S150
4. Pe´rez-Trallero E, Garcı´a-de-la-Fuente C, Garcı´a-Rey C, Ba-
quero F, Aguilar L, Dal-Re´ R, Garcı´a-de-Lomas J, the Spanish
surveillance group for respiratory pathogens (2005) Geo-
graphical and ecological analysis of resistance, coresistance,
and coupled resistance to antimicrobials in respiratory patho-
genic bacteria in Spain. Antimicrob Agents Chemother 49:
1965–1972
5. Serrano I, Ramirez M, the Portuguese surveillance group for the
study of respiratory pathogens, Melo-Cristino J (2004) Invasive
Streptococcus pneumoniae from Portugal: implications for vac-
cination and antimicrobial therapy. Clin Microbiol Infect 10:
652–656
2
